-
Back-to-school in Cuba a grim day with shortages of everything
-
US strikes Iran in latest tit-for-tat attacks
-
Canadian minister says Russia's G20 presence sparked 'discomfort'
-
China's Xi arrives in Egypt as US sanctions threat looms over Iran links
-
IMF reaches agreement with Senegal on new $2.2 bn loan programme
-
Car bomb at Colombian police station kills one, injures 11
-
Germany blames Russia for airport drone incident, hits back with sanctions
-
Rain delays start of play on US Open
-
Iran president urges return to truce, hails Russian support
-
Man City agree blockbuster deal to sign Chelsea star Fernandez: reports
-
Aster and World Liberty Financial Launch USD1 RWA Boost: Phase 1, Offering 125M $WLFI + 6.25M USD1 in Rewards
-
Alkemya Metacore Secures $50M via Tokenised Equity to Scale Nickel Energy and Security Tech
-
Tronchon sprints to Vuelta stage 10 win, Mas keeps red jersey
-
Man City chase Fernandez, Arsenal sell Jesus on deadline day
-
Germany defender Rudiger announces international retirement
-
EU says Russian 'hybrid attacks' won't halt aid to Ukraine
-
Musk defends AI data centers, slams EU rules at G20
-
Explosives used in sabotage attack on German power lines
-
Activists blame Kenya for Ugandan opposition figure's plight
-
Nepali families hold symbolic funerals for missing after floods
-
Iran president offers US olive branch, hails Russian support
-
Newcastle sign Lille forward Fernandez-Pardo
-
TrustFinance Community Choice Awards 2026 Opens Global Voting
-
Even at Elysee, phones are handed in, Macron tells French pupils
-
Nepal disaster a climate 'warning signal': foreign minister
-
Chelsea agree to sign Atalanta's Ahanor, with Palace loan for this season
-
France winger Diaby returns to Leverkusen until 2031
-
Chelsea sign Atalanta's Ahanor and loan him to Palace
-
Barcelona confirm Jesus arrival from Arsenal
-
UK chalks up hottest summer on record for second year running
-
EU official says it's not time to 'normalize' Russia at G20 finance talks
-
China's Xi visits Egypt as US sanctions threat looms over Iran links
-
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
-
RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology
-
TrendEadvisor Launches Global Multi-Asset Platform Combining Online Investing with Social Trading
-
Global bond sell-off deepens on inflation concerns
-
India's top court drops criminal cases against protesters
-
Germany's far-right AfD promises 'boom' but economists fear worst
-
Philippine couple married in hip-deep floodwaters
-
Former England captain Stokes signs for Adelaide Strikers
-
Villa sign Senegal winger Mbaye from PSG
-
Pakistan selector and ex-captain Misbah resigns after coach sacked
-
Former Peru minister last-minute contender for UN labour agency helm
-
Shein flattens on Hong Kong debut facing global headwinds
-
Messi legacy will 'live forever', says Beckham
-
Eurozone inflation hits three-year high at 3.3% in August
-
'Literally tasting the smoke': Malaysians suffer as haze worsens
-
Man City chase Fernandez, Arsenal eye Alvarez on deadline day
-
Kyiv's defences, 'hybrid' threat from Moscow headline EU talks
-
El Nino hammering Peru anchovy fishing: industry officials
DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025
"For DEXIS, 2024 was a year of tremendous innovation, as we continue to provide dental professionals with the most powerful, efficient and time-saving diagnostic tools and technologies," DEXIS President Robert Befidi said. "We are proud of our progress and will bring that momentum with us in 2025 as we unveil exciting, industry-changing initiatives."
QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with other AI-powered imaging solutions. The company also announces that 2025 will bring further innovations, with presentations at two major dental technology conferences.
The company enhanced its portfolio of award-winning imaging solutions in 2024, beginning with the February 2024 launch of the DEXIS digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow. The platform combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning to aid clinicians through their entire digital workflow from diagnosis to delivery. The open imaging system ensures that clinicians have the freedom to customize workflows and that patients, labs, and staff have the appropriate visibility, creating a seamless experience.
May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor, built on the success of its predecessor, the best-selling DEXIS Titanium Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI Dental Findings, an integrated offering that automatically identifies and highlights 6 common dental findings. The sensor's housing also incorporates subtle design changes that make it more resistant to drops and wear.
In August, the company announced the launch of DEXIS™ Connect Pro, which provides proactive monitoring of DEXIS CBCT and intraoral sensor devices through IoT technology. It connects DEXIS customers with more than 100 DEXIS technical support agents, automatically arranging support, preventative maintenance, or equipment replacements if performance issues are detected. By keeping digital equipment operating without interruption, the Connect Pro solution enhances office productivity and consistent patient care for dental professionals who rely on DEXIS technology.
DEXIS continued to actively improve its solutions with the September 2024 release of the ORTHOPANTOMOGRAPH™ OP 3D™ EX X-ray platform. Designed specifically for general practitioners looking to expand their diagnostic capabilities with 3D imaging, the OP 3D EX has a wide range of field of view sizes to support multiple clinical indications. Updates to the DTX Studio™ Clinic software provided advanced tools and new functionality that allows practitioners to plan an implant treatment and generate a surgical guide chairside, in less than three minutes.
DEXIS envisions 2025 as another year of ground-breaking advancements in technology and customer service. Projects currently in production or development include:
The first intraoral scanner developed entirely by DEXIS
AI enhancements across the ecosystem to increase efficiency and productivity
An exciting innovation within the 3D imaging portfolio
Updates to enhance the implant workflow in DTX Studio Clinic
DEXIS expects to begin rolling out these initiatives at two major 2025 industry meetings: the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne, Germany, in March.
The Chicago Dental Society meeting, February 20-25 at McCormick Place West, is the organization's 160th annual midwinter conference and offers more than 200 courses on dental medicine. It draws both U.S. and international dental professionals as well as hundreds of exhibitors.
The International Dental Show, March 25-29, is the world's leading trade fair for the dental sector. The biennial event is known as a trend-setting event, where major manufacturers unveil advances in technology for the top decision-makers in dentistry.
As one of the world's leading developers of dental imaging technologies, DEXIS sees both events as essential venues for showcasing its products and connecting with DEXIS owners." There are more than 150,000 DEXIS dental imaging devices in use worldwide which is a testament to our mission to transform practices and patient smiles globally," Befidi said. "Every year, we build on our long tradition of innovation and successes, learn from our lessons, and aim to provide innovative solutions and exceptional service to our customers."
Visit the company's website at www.dexis.com to stay informed about the latest industry news, product information, and upcoming events.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide you with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances the way you diagnose, accelerates your workflow, and delivers simpler treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
Contact Information
Maria Penaloza
Media & Content Strategy Manager
[email protected]
Julie Hansoulle
Sr. Marketing Manager DEXIS EU
[email protected]
SOURCE: Envista
View the original press release on ACCESS Newswire
K.Sutter--VB